Margaret A. Hamburg, M.D.
Commissioner U.S. Food and Drug Administration
NTI | bio Convenes Experts to Establish Global Entity Dedicated to Reducing Biotechnology Risks
An interdisciplinary group of international leaders and experts came together virtually on May 21 to advance the mission and scope of a prospective global entity dedicated to reducing biotechnology risks, promoting global biosecurity norms, and strengthening international oversight of life sciences research. The 15+ experts from international organizations, academia, philanthropy, and biotechnology industry comprise a steering group that will advise NTI | bio on its work to shape the entity’s structure, governance, and relationship to key stakeholders.
The meeting builds on momentum established during a September 2020 meeting convened by NTI Co-Chair and CEO Ernest J. Moniz that brought together global experts to discuss the need to establish an international entity to oversee global biosecurity norms and best practices and to further work to establish an international Common Mechanism for DNA synthesis screening.
The COVID-19 pandemic has highlighted the urgency of these efforts by demonstrating the severe impact of biological events in terms of loss of life, as well as economic and political disruption on a global scale. Adding to the risk: gaps in the global biosecurity architecture regarding governance of bioscience and biotechnology and the increasing threat of deliberate misuse or catastrophic laboratory accidents. A dedicated entity can reduce these risks by developing global biosecurity norms and innovative tools and governance approaches that can be used by industry, academia, governments, and funders in a collective effort to reduce emerging biological risks associated with rapid technology advances.
This project is part of the Biosecurity Innovation and Risk Reduction Initiative (BIRRI). Learn more about BIRRI and related initiatives here.
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
More News
NTI | bio Engages Global Leaders at GHS2026 in Kuala Lumpur
NTI | bio experts will take part in several GHS2026 sessions, including a preview of findings from the forthcoming Africa Health Security (AHS) Index and a timely discussion on strengthening health security partnerships amid declining resources.
NTI and CACDA Issue Joint Statement Calling for Stronger Biosecurity and Responsible AI-Biotechnology Innovation
Amid rapid advances in bioscience and as artificial intelligence reshapes global technological capabilities, the Nuclear Threat Initiative (NTI) and the China Arms Control and Disarmament Association (CACDA) are jointly calling for action to strengthen biosecurity and oversight and engage in responsible practices to prevent accidents or misuse.
New NTI Framework Tackles Misuse Risks in AIxBio Tools
New NTI | bio paper calls on tool developers and other AIxBio stakeholders to implement a managed access approach—allowing only validated users to access those biological AI models that contribute to biosecurity risks—to help reduce the risk that such tools will be deliberately misused to cause harm.
